Lucintel Research Outlines Growth of Global Human Vaccine Industry


   January 1 2013
The global vaccine industry comprises primarily human vaccine production. The annual revenue of this industry is forecast to reach an estimated $41.85 billion by 2018, with good growth over the next five years. Pfizer entered the top five player list in 2012 replacing Wyeth. Sanofi Aventis, Novartis AG, Merck Company, and GlaxoSmithKline are the other players in the top five players list.

Lucintel, a leading global Management Consulting and market research firm, has conducted a competitive analysis of the industry and presents its findings in “Global Human Vaccine Industry 2013-2018: Trend, Profit, and Forecast Analysis.” North America dominates this industry. India and China are rapidly growing as vaccine production hubs with strong domestic demand.

Lucintel's report gives a brief overview of the industry challenges. The global human vaccine industry is currently growing at a double-digit rate although there are numerous challenges for the major players. Competitive rivalry is moderate to high in this industry, and the threat of new entrants is low due to high capital requirements and the comprehensive, rigorous approval process. In addition, these approval processes are a major challenge for the manufacturers due to their stringent rules. Developing vaccines for adult and pediatric diseases requires high research cost. Expiration of patents is another challenge faced by vaccine manufacturers.

Despite these challenges, the industry enjoys some strong drives, as the study highlights. The global economy is recovering after the recession, and increased incomes and lower cost of vaccines have helped more infants and children become immunized, especially in the Rest of the World and Asia Pacific regions. Various countries’ national immunization programs, effectively run by nongovernmental organizations such as WHO, UNICEF, and GAVI, are a key factor in fueling growth in the vaccine industry.

This market report is an indispensable reference guide for vaccine manufacturers, researchers, people working with community health programs, investors, executives, distributors, and many more that operate in this market. To make business, investment, and strategic decisions, appropriate and useful information is needed, which is fulfilled by this market report.

For a detailed table of contents and pricing information on this timely, insightful report, contact Lucintel at +1-972-636-5056 or via email at helpdesk@lucintel.com. Lucintel’s Opportunity screening and Business Strategy Consulting services have supported decision makers in achieving their growth objectives.

Lucintel Corporate Customers

Market Entry, M & A, Opportunity Screening,...

Private Equity Customers

Buy Side Services (target screening, due diligence, ..)

Market Research Reports

Aerospace & Defense [44]
Chemical [101]
Composites & Advanced Materials [100]
Construction & Industrial [40]
Consumer and Retail [78]
Economic Analysis [86]
Energy & Utility [68]
Finance & Services [10]
Healthcare [25]
Media & Entertainment [16]
Metals & Mining [16]
Technology & Telecommunication [49]
Transportation [76]

Customer Quotes

"With more than 20 years experience in the industry, this is the first time we have come across such an extensive market analysis for our industry." Ven Cote, CEO, ZCL

"The insights we gained from Lucintel work helped with our business plan…a wonderful professional job…" Mike Jackson, Stahlin

"The report from Lucintel is useful not only for business planners, but also for the technology officers wanting to create a roadmap …" Dr. Giulio Ranzo, Booz Allen

"The information is so comprehensive, it has allowed us to identify & focus our business development efforts. It saved months of leg-work." Bill Barz, L&L Products

"We bought Lucintel report because it is the best report about our industry…a complete and appropriate analysis." Cesare Andrenacci, Ferretti

Quick Query

Hexcel Corporation to Acquire Oxford Performance Materials’ Aerospace & Defense Business ...
FACC Wins Additional Order for Bombardier C Series...
Spirit AeroSystems Plans Major Expansion, Job Growth in Wichita, Kan....
Diab Signs Long-Term Contracts ...
CPS’ HybridTech Armor Undergoing U.S. Navy Sea Trials...

Follow us on